Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
Einat B. Vitner, Roy Avraham, Boaz Politi, et al.
Life Science Alliance (2021) Vol. 5, Iss. 1, pp. e202101168-e202101168
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects
Heloísa D’Ávila, Claudia Natércia Rocha Lima, Pollianne Garbero Rampinelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 640-640
Open Access | Times Cited: 20
Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection
Jiakai Hou, Yanjun Wei, Jing Zou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 30
A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants
Scotland Farley, Jennifer Kyle, Hans C. Leier, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34
SARS‐CoV‐2 ORF3a expression in brain disrupts the autophagy–lysosomal pathway, impairs sphingolipid homeostasis, and drives neuropathogenesis
Hongling Zhu, Colleen Byrnes, Y Terry Lee, et al.
The FASEB Journal (2023) Vol. 37, Iss. 5
Open Access | Times Cited: 14
Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction
Samantha Lodge, Nathan G. Lawler, Nicola Gray, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11614-11614
Open Access | Times Cited: 11
Starve a cold or feed a fever? Identifying cellular metabolic changes following infection and exposure to SARS-CoV-2
Emma K. Loveday, Hope D. Welhaven, Ayten Ebru Erdogan, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0305065-e0305065
Open Access
Recent Progress in the Development of Opaganib for the Treatment of Covid-19
Charles D. Smith, Lynn W. Maines, Staci N. Keller, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2199-2211
Open Access | Times Cited: 18
Metatranscriptomic analysis revealed Prevotella as a potential biomarker of oropharyngeal microbiomes in SARS-CoV-2 infection
Sifen Lu, Yongzhao Zhou, Ya Hu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10
Virus infection and sphingolipid metabolism
Juncheng Dai, Yiyi Feng, Ying Liao, et al.
Antiviral Research (2024) Vol. 228, pp. 105942-105942
Closed Access | Times Cited: 3
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements
Fernando Carvalho Neuenschwander, Ofra Barnett‐Griness, Stefania Piconi, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1767-1767
Open Access | Times Cited: 3
A platelet lipidomics signature in patients with COVID-19
Laura Goracci, Eleonora Petito, Alessandra Di Veroli, et al.
Platelets (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 8
Altered sphingolipid pathway in SARS-CoV-2 infected human lung tissue
Rabisa J. Khan, Sierra L. Single, Christopher S. Simmons, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Direct lipid interactions control SARS-CoV-2 M protein conformational dynamics and virus assembly
Mandira Dutta, Kimberly A. Dolan, Souad Amiar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Network Pharmacology Study to Elucidate the Key Targets of Underlying Antihistamines against COVID-19
Ki‐Kwang Oh, Md. Adnan, Dong Ha Cho
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 4, pp. 1597-1609
Open Access | Times Cited: 11
Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14340-14340
Open Access | Times Cited: 11
Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system
Roy Avraham, Sharon Melamed, Hagit Achdout, et al.
Brain Communications (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 6
Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection
Shilan Chen, Jianhao Liang, Dingqiang Chen, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 209-222
Closed Access | Times Cited: 6
Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID‐19 vaccine booster shot against Omicron SARS‐CoV‐2 infection
Beili Wang, Wenjing Yang, Yexin Tong, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 6
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus
Daniella Cesar-Silva, Filipe S. Pereira‐Dutra, Ana L.M. Giannini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19
Diana Mota Toro, Pedro V. da Silva‐Neto, Jonatan C. S. de Carvalho, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1938-1938
Open Access | Times Cited: 5
The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2
Simona Fenizia, Melania Gaggini, Cristina Vassalle
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7956-7973
Open Access | Times Cited: 5
Integrated multi-omics analyses identify key anti-viral host factors and pathways controlling SARS-CoV-2 infection
Jiakai Hou, Yanjun Wei, Jing Zou, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 8
Comprehensive analysis of immunogenic cell death-related gene and construction of prediction model based on WGCNA and multiple machine learning in severe COVID-19
Chunyu Li, Ke Wu, Rui Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
The unique metabolic and lipid profiles of patients with severe COVID-19 compared to severe community-acquired pneumonia: a potential prognostic and therapeutic target
Elsa D. Ibáñez-Prada, J. Luis Guerrero, Ingrid G. Bustos, et al.
Expert Review of Respiratory Medicine (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top